Management of chronic obstructive pulmonary disease: An emphasis on recently approved medications and products in the pipeline; Focus On Boceprevir: A new oral protease inhibitor for the treatment of chronic hepatitis C
Oncologists: Prior Authorizations Lead to Delays in Getting Cancer Meds
Insurance hurdles and the complexities of prior authorization create barriers to care, according to oncologists in a new survey by Sermo.
Read More
Novo Nordisk Offers Wegovy Through Telehealth Providers, Including Hims & Hers
Novo Nordisk has teamed up with Hims & Hers Health, LifeMD and Ro for cash-paying patients to access Wegovy injection 2.4 mg through its NovoCare Pharmacy.
Food Retailer Giant Eagle Selects EmpiRx Health as PBM
Giant Eagle also helped EmpiRx Health create a national pharmacy care network that was purpose-built for pharmacy and grocery chains.
Part D Plans Cover a Larger Share of Medicare Beneficiaries in Rural Counties
Nationwide, 58% of Medicare beneficiaries living in rural areas are enrolled in stand-alone prescription drug plans in 2025.
FDA Issues CRL for Extended Dosing of Eylea HD
The complete response letter did not identify any issues with the safety or efficacy of Eylea HD, Regeneron officials said.
FDA Approves Dupixent for Inflammatory Skin Disease
Chronic spontaneous urticaria is chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden and debilitating hives and recurring itch.